The objective of this review was to evaluate the clinical efficacy and safety of remifentanil in the management of labor pain. Although neuraxial analgesia is the best option during labor, alternative analgesic options are needed for patients with contraindications. Using a systematic literature search, clinical outcomes of remifentanil for labor pain have been summarized. Also, comparisons of remifentanil to other options including meperidine, epidural analgesia, fentanyl, and nitrous oxide are provided. Based on the literature review, remifentanil is associated with high overall maternal satisfaction and favorable side-effect profile. However, due to the low reporting of adverse events, large, randomized controlled trials are needed to evaluate maternal and neonatal safety adequately and determine the optimal dosing needed to provide effective analgesia. While remifentanil is a feasible alternative for patients who cannot or do not want to receive epidural analgesia, administration should be monitored closely for potential adverse effects.
Keyphrases
- pain management
- postoperative pain
- neuropathic pain
- chronic pain
- ultrasound guided
- spinal cord
- randomized controlled trial
- systematic review
- birth weight
- spinal cord injury
- pregnancy outcomes
- clinical trial
- pregnant women
- study protocol
- weight loss
- gestational age
- climate change
- preterm birth
- electronic health record